IT9048261A0 - Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione. - Google Patents

Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.

Info

Publication number
IT9048261A0
IT9048261A0 IT4826190A IT4826190A IT9048261A0 IT 9048261 A0 IT9048261 A0 IT 9048261A0 IT 4826190 A IT4826190 A IT 4826190A IT 4826190 A IT4826190 A IT 4826190A IT 9048261 A0 IT9048261 A0 IT 9048261A0
Authority
IT
Italy
Prior art keywords
treatment
application
pharmaceutical composition
respiratory disorders
respiratory
Prior art date
Application number
IT4826190A
Other languages
English (en)
Other versions
IT1241997B (it
IT9048261A1 (it
Inventor
James Barry Douglas Palmer
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898920391A external-priority patent/GB8920391D0/en
Priority claimed from GB898923645A external-priority patent/GB8923645D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IT9048261A0 publication Critical patent/IT9048261A0/it
Publication of IT9048261A1 publication Critical patent/IT9048261A1/it
Application granted granted Critical
Publication of IT1241997B publication Critical patent/IT1241997B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Thermistors And Varistors (AREA)
IT48261A 1989-09-08 1990-09-07 Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione. IT1241997B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898920391A GB8920391D0 (en) 1989-09-08 1989-09-08 Medicaments
GB898923645A GB8923645D0 (en) 1989-10-20 1989-10-20 Medicaments

Publications (3)

Publication Number Publication Date
IT9048261A0 true IT9048261A0 (it) 1990-09-07
IT9048261A1 IT9048261A1 (it) 1992-03-07
IT1241997B IT1241997B (it) 1994-02-02

Family

ID=26295893

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48261A IT1241997B (it) 1989-09-08 1990-09-07 Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.

Country Status (11)

Country Link
EP (1) EP0416950B1 (it)
JP (1) JP3042866B2 (it)
AT (1) ATE92762T1 (it)
AU (1) AU644094B2 (it)
CA (1) CA2024872C (it)
DE (1) DE69002718T2 (it)
DK (1) DK0416950T3 (it)
FR (1) FR2651678B1 (it)
GB (1) GB2235626B (it)
IT (1) IT1241997B (it)
NZ (1) NZ235222A (it)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270305A (en) 1989-09-08 1993-12-14 Glaxo Group Limited Medicaments
PT613371E (pt) * 1991-12-18 2002-07-31 Astrazeneca Ab Nova combinacao de formoterol e budesonido
US6054487A (en) * 1997-03-18 2000-04-25 Basf Aktiengesellschaft Methods and compositions for modulating responsiveness to corticosteroids
TR199902615T2 (xx) * 1997-03-18 2000-03-21 Basf Aktiengesellschaft Kortikosteroidlere verilen cevab�n mod�lasyonuna y�nelik metodlar ve kompozisyonlar.
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
IT1303692B1 (it) * 1998-11-03 2001-02-23 Chiesi Farma Spa Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione.
CA2347856C (en) 1998-11-13 2009-02-17 Jago Research Ag Dry powder for inhalation
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
AU7127600A (en) * 1999-09-17 2001-04-17 Basf Aktiengesellschaft Methods and compositions for modulating responsiveness to corticosteroids
GB0009617D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
FI20002215A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit
FI20002216A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit astman hoitoon
US7258118B2 (en) 2002-01-24 2007-08-21 Sofotec Gmbh & Co, Kg Pharmaceutical powder cartridge, and inhaler equipped with same
DE10202940A1 (de) 2002-01-24 2003-07-31 Sofotec Gmbh & Co Kg Patrone für einen Pulverinhalator
EP1572217B1 (en) 2002-12-12 2008-08-20 Nycomed GmbH Combination medicament of r,r-formoterol and ciclesonide
SE527069C2 (sv) 2003-06-19 2005-12-13 Mederio Ag Förfarande och anordning för administrering av läkemedelspulver
CA2534934A1 (en) 2003-08-06 2005-02-17 Galephar M/F Advantageous combinations for inhalation of nacystelyn and bronchodilators
DE602005023690D1 (de) 2004-07-16 2010-11-04 Almirall Sa Inhalator für die Abgabe von pharmzeutischen Pulver, und ein Pulverkassette zur Verwendung mit diesem Inhalator
EP2063940B1 (en) 2006-12-22 2012-01-11 Almirall, S.A. Inhalation device for drugs in powder form
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
DK2435024T3 (en) 2009-05-29 2016-10-24 Pearl Therapeutics Inc Compositions for the respiratory delivery of active agents and related methods and systems
US20140275517A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate
GB2107715B (en) * 1981-10-19 1985-11-13 Glaxo Group Ltd Micronised beclomethasone dipropionate monohydrate and powder inhalation compositions containing it
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
FR2588474B1 (fr) * 1985-10-16 1987-11-27 Cird Compositions synergetiques anti-inflammatoires a base d'un corticosteroide et d'un beta agoniste

Also Published As

Publication number Publication date
FR2651678A1 (fr) 1991-03-15
IT1241997B (it) 1994-02-02
DE69002718T2 (de) 1993-12-23
GB2235626A (en) 1991-03-13
DK0416950T3 (da) 1993-10-11
EP0416950B1 (en) 1993-08-11
JP3042866B2 (ja) 2000-05-22
DE69002718D1 (de) 1993-09-16
GB9019651D0 (en) 1990-10-24
AU644094B2 (en) 1993-12-02
CA2024872A1 (en) 1991-03-09
IT9048261A1 (it) 1992-03-07
JPH03167119A (ja) 1991-07-19
AU6226090A (en) 1991-03-14
FR2651678B1 (fr) 1992-04-30
GB2235626B (en) 1994-02-09
EP0416950A1 (en) 1991-03-13
NZ235222A (en) 1992-11-25
CA2024872C (en) 2002-07-09
ATE92762T1 (de) 1993-08-15

Similar Documents

Publication Publication Date Title
IT9048260A0 (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
IT9048261A0 (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
KR920701466A (ko) 면역조절 장애 치료를 위한 제약학적 생성물
IT1231434B (it) Composizione farmaceutica endovenosa e procedimento per la sua preparazione.
NL193218B (nl) Werkwijze voor de bereiding van roestvrij staal.
IT1247784B (it) Composizione e metodo per la riduzione dell'appetito
IT8922164A0 (it) Composizione farmaceutica e procedimento per la sua preparazione
IT1240302B (it) Struttura di scocca,procedimento ed apparecchio per la sua produzione.
IT8920917A0 (it) Processo per la preparazione di peraloeteri da peraloolefine e nuovi peraloeteri ottenuti.
FR2666334B1 (fr) Procede continu de preparation d'acrylamides et de methacrylamides n-substitues.
IT9020968A0 (it) Metodi e composizioni farmaceutiche per il trattamento di malattie oftalmiche
IT1210935B (it) Composizione farmaceutica per il trattamento di malattie cardiovascolari.
ITRM940322A0 (it) "composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione edapplicazione".
MX9203208A (es) Composicion farmaceutica y metodo para el tratamiento de trastornos digestivos.
DE520834T1 (de) PP14 oder Antikörper gegen PP14 enthaltende pharmazeutische Zusammensetzung zur Behandlung von Immunsystemstörungen.
IT8821369A0 (it) Composizione farmaceutica utile per il trattamento di malattie cardiovascolari.
IT8520736A0 (it) Composizione medicinale e metodo per la cura delle periartriti ed affezioni similari.
IT8248390A0 (it) N-[4-(3-amminopropil)amminobutil]2,2-diidrossiotanammide come immuno -stimolante ed intermedio per laproduzione di sostanze carcinostati che, e procedimento per la sua preparazione
IT1231944B (it) Composizione farmaceutica per il trattamento di protozoosi, particolarmente della tripasonomiasi comprendente d-carnitina o un alcanoilderivato della d-carnitina
IT8720352A0 (it) Sostanza profilattica e terapeutica per disturbi epatici.
IT8522576A0 (it) Composizione farmaceutica per il trattamento di disturbi respiratori, muscolari e articolari.
IT8719390A0 (it) Composizione farmaceutica per la prevenzione e il trattamento dell'aterosclerosi.
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.
IT8719512A0 (it) Composizione farmaceutica eprocedimento per la sua preparazione.
ITMI942047A0 (it) Metodo ionoforetico per la somministrazione di farmaci e composizione farmaceutica solida per la sua realizzazione

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970910